Wilson's disease associated with psychotic episode - case report
DOI:
https://doi.org/10.33448/rsd-v11i3.26095Keywords:
Copper-transporting ATPases; Copper; Psychotic disorders; Marijuana abuse; Alcohol-induced disorders.Abstract
Wilson's Disease is a rare genetic disorder characterized by a failure in copper metabolism, which promotes copper deposition in both the liver and the brain, which can lead to serious complications if not diagnosed early and treated properly. The present case report exposes a psychotic episode in a patient previously diagnosed with Wilson's Disease and undergoing treatment, who exhibited failures in the follow-up of therapy associated with the excessive use of alcoholic beverages and especially of marijuana cigarettes since adolescence. Therefore, a bibliographical research on the themes was carried out and the discussion permeated about the possible correlations of these factors for the case described. It was concluded that the patient likely had an underdiagnosed psychiatric underlying illness that was exacerbated by accumulation of copper and drug use, causing the psychotic break to occur and thus later allowing for its diagnosis.
References
Anderson, L. A., Hakojarvi, S. L., & Boudreaux, S. K. (1998). Zinc Acetate Treatment in Wilson’s Disease. Annals of Pharmacotherapy, 32(1), 78–87. https://doi.org/10.1345/aph.17075
Brewer, G. J., Terry, C. A., Aisen, A. M., & Hill, G. M. (1987). Worsening of Neurologic Syndrome in Patients With Wilson’s Disease With Initial Penicillamine Therapy. Archives of Neurology, 44(5), 490–493. https://doi.org/10.1001/archneur.1987.00520170020016
Brito, J. C. de F., Coutinho, M. de A. P., Almeida, H. J. F. de, & Nóbrega, P. V. da. (2005). Doença de Wilson: diagnóstico clínico e sinais das “faces do panda” à ressonância magnética. Relato de caso. Arquivos de Neuro-Psiquiatria, 63(1), 176–179. https://doi.org/10.1590/s0004-282x2005000100034
Czlonkowska, A., Gajda, J., & Rodo, M. (1996). Effects of long-term treatment in Wilson’s disease with D-penicillamine and zinc sulphate. Journal of Neurology, 243(3), 269–273. https://doi.org/10.1007/BF00868525
Członkowska, A., Litwin, T., & Chabik, G. (2017). Wilson disease: neurologic features. Handbook of Clinical Neurology, 142, 101–119. https://doi.org/10.1016/B978-0-444-63625-6.00010-0
Dhawan, A., Taylor, R. M., Cheeseman, P., De Silva, P., Katsiyiannakis, L., & Mieli-Vergani, G. (2005). Wilson's disease in children: 37-year experience and revised King's score for liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 11(4), 441–448.
Dubois, R. S., Rodgerson, D. O., & Hambidge, K. M. (1990). Treatment of Wilson’s disease with triethylene tetramine hydrochloride (Trientine). Journal of Pediatric Gastroenterology and Nutrition, 10(1), 77–81. https://doi.org/10.1097/00005176-199001000-00015
Faia, R., Lemos, L. M. de, Mourão-Júnior, C. A., & Andreazzi, A. E. (2016). Copper metabolism and Wilson’s disease: a review. Revista Médica de Minas Gerais, 26. https://doi.org/10.5935/2238-3182.20160133
Fernando, M., van Mourik, I., Wassmer, E., & Kelly, D. (2020). Wilson disease in children and adolescents. Archives of Disease in Childhood, 105(5), 499–505. https://doi.org/10.1136/archdischild-2018-315705
Guyton, A.C. (2006). Tratado de fisiologia médica. Elsevier Brasil.
Lance, L.L., Goldman, M.P., Armstrong, L.L., & Lacy, C.F. (2009). Drug Information Handbook, 18th.
Linn, F. H. H., Houwen, R. H. J., van Hattum, J., van der Kleij, S., & van Erpecum, K. J. (2009). Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients. Hepatology (Baltimore, Md.), 50(5), 1442–1452. https://doi.org/10.1002/hep.23182
Mulligan, C., & Bronstein, J. M. (2020). Wilson Disease: An Overview and Approach to Management. Neurologic Clinics, 38(2), 417–432. https://doi.org/10.1016/j.ncl.2020.01.005
Nazer, H., Ede, R. J., Mowat, A. P., & Williams, R. (1986). Wilson’s disease: clinical presentation and use of prognostic index. Gut, 27(11), 1377–1381. https://doi.org/10.1136/gut.27.11.1377
Pfeiffer, R. F. (2016). Wilson Disease. CONTINUUM: Lifelong Learning in Neurology, 22(4), 1246–1261. https://doi.org/10.1212/con.0000000000000350
Poujois, A., & Woimant, F. (2018). Wilson’s disease: A 2017 update. Clinics and Research in Hepatology and Gastroenterology, 42(6), 512–520. https://doi.org/10.1016/j.clinre.2018.03.007
Poujois, A., Mikol, J., & Woimant, F. (2017). Wilson disease: brain pathology. Handbook of Clinical Neurology, 142, 77–89. https://doi.org/10.1016/B978-0-444-63625-6.00008-2
Ribeiro, M., Marques, A. C. P. R., Laranjeira, R., Alves, H. N. P., Araújo, M. R. de, Baltieri, D. A., Bernardo, W. M., Lagp, C., Karniol, I. G., Kerr-Corrêa, F., Nicastri, S., Nobre, M. R. C., Oliveira, R. A. de, Romano, M., Seibel, S. D., & Silva, C. J. da. (2005). Abuso e dependência da maconha. Revista Da Associação Médica Brasileira, 51, 247–249. https://doi.org/10.1590/S0104-42302005000500008
Scheiber, I. F., Brůha, R., & Dušek, P. (2017). Pathogenesis of Wilson disease. Elsevier. https://pubmed.ncbi.nlm.nih.gov/28433109/
Silva, A. C. da, Colósimo, A. P., & Salvestro, D. (n.d.). Doença de Wilson (degeneração hepatolenticular): revisão bibliográfica e relato de caso. Rmmg.org, 20(Esp), 404–411. Retrieved December 27, 2021, from http://rmmg.org/artigo/detalhes/1175
Sócio, S. de A., Ferreira, A. R., Fagundes, E. D. T., Roquete, M. L. V., Pimenta, J. R., Campos, L. de F., & Penna, F. J. (2010). Doença de Wilson em crianças e adolescentes: diagnóstico e tratamento. Revista Paulista de Pediatria, 28, 134–140. https://doi.org/10.1590/S0103-05822010000200002
Sturniolo, G. C., Mestriner, C., Irato, P., Albergoni, V., Longo, G., & D’Incà, R. (1999). Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson’s disease patients. The American Journal of Gastroenterology, 94(2), 334–338. https://doi.org/10.1111/j.1572-0241.1999.851_w.x
Oliveira-Júnior, H.P. (2013). Dependência química: maconha.Universidade Federal do Maranhão. UNASUS/UFMA. Disponível em: Ares.unasus.gov.br. https://ares.unasus.gov.br/acervo/handle/ARES/2048
Walshe, J. M. (1982). TREATMENT OF WILSON’S DISEASE WITH TRIENTINE (TRIETHYLENE TETRAMINE) DIHYDROCHLORIDE. The Lancet, 319(8273), 643–647. https://doi.org/10.1016/s0140-6736(82)92201-2
Zimbrean, P., & Seniów, J. (2017). Cognitive and psychiatric symptoms in Wilson disease. Handbook of) Clinical Neurology, 142, 121–140. https://doi.org/10.1016/B978-0-444-63625-6.00011-2
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Raianny Cunha Duarte; Clara Porto de Souza; Andressa Paes Medeiros de Freitas; Letícia de Almeida Dutra ; Douglas Reis Abdalla; Geisa Perez Medina Gomide; Fernanda Oliveira Magalhães
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.